NTRA insider trades & Congress trades
Natera, Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 158 open-market insider transactions in Natera, Inc. (NTRA) (0 purchases with code P and 158 sales with code S), the most recent on November 3, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 146 sales by 7 ($107.4M).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 470 | $391.49 | $184K | – |
| Nov 2, 2026 | Sheena Jonathan | – | Sell | 3 | $388.20 | $1K | – |
| Nov 2, 2026 | Sheena Jonathan | – | Sell | 109 | $400.29 | $44K | – |
| Nov 2, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 17 | $388.20 | $7K | – |
| Nov 2, 2026 | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | Sell | 731 | $400.29 | $293K | – |
| Nov 2, 2026 | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | Sell | 7 | $388.20 | $3K | – |
| Nov 2, 2026 | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | Sell | 334 | $400.29 | $134K | – |
| Nov 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 9 | $388.20 | $3K | – |
| Nov 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 410 | $400.29 | $164K | – |
| Nov 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 200 | $405.26 | $81K | – |
| Nov 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 432 | $406.94 | $176K | – |
| Nov 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 408 | $408.08 | $166K | – |
| Nov 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 520 | $409.46 | $213K | – |
| Nov 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 120 | $410.72 | $49K | – |
| Nov 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 120 | $411.73 | $49K | – |
| Nov 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 120 | $412.88 | $50K | – |
| Nov 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 80 | $414.16 | $33K | – |
| Nov 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 760 | $415.52 | $316K | – |
| Nov 2, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 240 | $416.45 | $100K | – |
| Nov 2, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 7 | $388.20 | $3K | – |
| Nov 2, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 295 | $400.29 | $118K | – |
| Nov 2, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 21 | $387.90 | $8K | – |
| Nov 2, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 914 | $400.29 | $366K | – |
| Nov 2, 2026 | Chapman Steven Leonard | CEO AND PRESIDENT | Sell | 2,866 | $415.64 | $1.19M | – |
| Nov 2, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 8 | $388.03 | $3K | – |
| Nov 2, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 317 | $400.29 | $127K | – |
| Oct 30, 2026 | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | Sell | 1,906 | $425.55 | $811K | – |
| Oct 28, 2026 | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | Sell | 968 | $426.34 | $413K | – |
| Oct 28, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 1,162 | $426.34 | $495K | – |
| Oct 28, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sell | 898 | $426.34 | $383K | – |
Showing the 30 most recent of 158 transactions.
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.